China Resources Medical Holdings Company Limited (1PH) — Cash Flow Quality Index
China Resources Medical Holdings Company Limited (1PH) has a Cash Flow Quality Index of 1.36x as of June 2023. Operating cash flow of €270.22 Million exceeds net income of €198.84 Million, indicating high earnings quality where cash backs reported profits. Explore China Resources Medical Holdings Company (1PH) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China Resources Medical Holdings Company Limited Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for China Resources Medical Holdings Company Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 1PH cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for China Resources Medical Holdings Company Limited (2017–2024)
Year-by-year earnings quality comparison for China Resources Medical Holdings Company Limited. For live market cap and the full company financial profile, see 1PH market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | €1.27 Billion | €565.88 Million | ▼ -51.6% |
| 2023 | 4.64x | €1.20 Billion | €257.68 Million | ▲ +2.9% |
| 2022 | 4.51x | €626.58 Million | €138.97 Million | ▲ +165.2% |
| 2021 | 1.70x | €710.43 Million | €417.92 Million | ▼ -18.1% |
| 2020 | 2.08x | €643.69 Million | €310.13 Million | ▲ +121.6% |
| 2019 | 0.94x | €366.05 Million | €390.87 Million | ▲ +20.8% |
| 2018 | 0.78x | €334.15 Million | €430.90 Million | ▼ -29.0% |
| 2017 | 1.09x | €459.54 Million | €421.03 Million | — |